Filing Details
- Accession Number:
- 0001181431-12-037231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-19 16:22:36
- Reporting Period:
- 2012-06-15
- Filing Date:
- 2012-06-19
- Accepted Time:
- 2012-06-19 16:22:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190126 | R James Mcnab | 4 Maguire Road Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-06-15 | 11,000 | $4.73 | 1,368,688 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-06-18 | 150,000 | $4.75 | 1,218,688 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-06-19 | 139,000 | $4.76 | 1,079,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 130,975 | Indirect | By McNab Family LLC |
| Common Stock | 200,000 | Indirect | By JR & MW Operating LP |
Footnotes
- These shares were sold between $4.68-$4.76/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- These shares were sold between $4.70-$4.78/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- These shares were sold between $4.73-$4.79/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
